Abstract:OBJECTIVE:To identify the manifestations and pathogenesis of idiopathic pulmonary fibrosis (IPF) after studying the clinical features of familial idiopathic pulmonary fibrosis (FIPF) and detecting relevant genes. METHODS:Seven persons with FIPF from one family of Han nationality in northern China, which had FIPF patients in three consecutive generations, were included in this study. The incidence age of the 7 subjects (4 males and 3 females) ranged from 30 to 57 years. The propositus was II-4, while the first person attacked by FIPF was I-1. Five patients (2 males, 3 females) in the second generation and one case in the third generation were found at the time of this study. The genetic characteristics of FIPF in this study were complied with the pattern of autosomal dominant inheritance. Imaging examinations and pulmonary function tests were conducted to confirm the diagnosis of pulmonary fibrosis. Meanwhile, personal information and clinical data such as imaging examinations and pathological tests were acquired; clinical features and manifestations were analyzed and compared; and pathological tests and gene detection were performed. RESULTS:The average survival time was 3 years, and poor response to glucocorticoid treatment was observed. Three patients had detailed clinical information, whose interstitial pneumonia related immunologic tests were negative. Concerning pulmonary function, three patients had significant decrease of diffusion function and obvious restrictive ventilatory disorder, with DLCO value as 50%, 23% and 46%, respectively. Among the 3 patients with complete imaging data, 1 was considered as UIP, while 2 as NSIP. The 3 subjects who had different imaging findings all responded poorly to glucocorticoid treatment, and two of them died. Genetic test for TERT, TERC and SFTPC in peripheral blood and autopsy were performed for II-4 but all were negative. CONCLUSIONS:The average death age of family members with FIPF was 50.2 years. The patients presented various imaging features and pathological findings. Glucocorticoid treatment may be ineffective, even for persons diagnosed as NSIP by lung biopsy.

Progress of study on etiology and diagnosis of idiopathic pulmonary fibrosis

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis

The Development in the Diagnosis of Idiopathic Pulmonary Fibrosis

Pathogenesis and clinical therapy of idiopathic pulmonary fibrosis

Research progress in diagnostic methods for idiopathic pulmonary fibrosis

Research progress of idiopathic pulmonary fibrosis and its treatment

Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history

Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management

Current progress in acute exacerbations of idiopathic pulmonary fibrosis

Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosis

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies

Advances in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review

Clinical evaluation on idiopathic pulmonary fibrosis.

Research progress of prognostic biomarkers of idiopathic pulmonary fibrosis

[Clinical and genetic study on familial idiopathic pulmonary fibrosis in a Chinese family].

Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis

Retrospective Study on Prognostic Factors of Idiopathic Pulmonary Fibrosis

Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis

Acute Exacerbation of Idiopathic Pulmonary Fibrosis:Clinical Analysis of 21 Cases